Beaumont Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $875K | Sell |
2,159
-87
| -4% | -$35.3K | 0.06% | 164 |
|
|
2025
Q1 | $1.12M | Buy |
2,246
+225
| +11% | +$112K | 0.09% | 135 |
|
|
2024
Q4 | $1.05M | Buy |
2,021
+402
| +25% | +$209K | 0.08% | 145 |
|
|
2024
Q3 | $1M | Sell |
1,619
-603
| -27% | -$373K | 0.08% | 145 |
|
|
2024
Q2 | $1.23M | Buy |
2,222
+23
| +1% | +$12.7K | 0.1% | 130 |
|
|
2024
Q1 | $1.28M | Buy |
2,199
+17
| +0.8% | +$9.88K | 0.11% | 124 |
|
|
2023
Q4 | $1.16M | Buy |
2,182
+33
| +2% | +$17.5K | 0.11% | 127 |
|
|
2023
Q3 | $1.09M | Buy |
2,149
+136
| +7% | +$68.8K | 0.11% | 116 |
|
|
2023
Q2 | $1.05M | Buy |
2,013
+76
| +4% | +$39.7K | 0.1% | 128 |
|
|
2023
Q1 | $1.12M | Buy |
1,937
+27
| +1% | +$15.6K | 0.11% | 106 |
|
|
2022
Q4 | $1.05M | Sell |
1,910
-9
| -0.5% | -$4.96K | 0.11% | 115 |
|
|
2022
Q3 | $973K | Sell |
1,919
-36
| -2% | -$18.3K | 0.09% | 116 |
|
|
2022
Q2 | $1.06M | Sell |
1,955
-124
| -6% | -$67.4K | 0.1% | 120 |
|
|
2022
Q1 | $1.23M | Buy |
2,079
+714
| +52% | +$423K | 0.09% | 140 |
|
|
2021
Q4 | $911K | Sell |
1,365
-330
| -19% | -$220K | 0.07% | 153 |
|
|
2021
Q3 | $974K | Sell |
1,695
-299
| -15% | -$172K | 0.08% | 140 |
|
|
2021
Q2 | $1.01M | Buy |
1,994
+142
| +8% | +$71.9K | 0.08% | 144 |
|
|
2021
Q1 | $845K | Sell |
1,852
-379
| -17% | -$173K | 0.07% | 157 |
|
|
2020
Q4 | $1.04M | Buy |
2,231
+1,700
| +320% | +$792K | 0.09% | 133 |
|
|
2020
Q3 | $235K | Sell |
531
-48
| -8% | -$21.2K | 0.02% | 287 |
|
|
2020
Q2 | $210K | Buy |
+579
| New | +$210K | 0.02% | 265 |
|
|
2020
Q1 | – | Sell |
-652
| Closed | -$212K | – | 287 |
|
|
2019
Q4 | $212K | Buy |
+652
| New | +$212K | 0.02% | 263 |
|